Pharming Group NV (PHAR) DEC/2025 Earning Prediction
Pharming Group NV (PHAR) is set to release its DEC/2025 earnings performance on 03/12 ET in Pre-Market trading. Consensus forecasts predict a revenue of 102.04M and an earnings per share (EPS) of 0.15 for the DEC/2025. With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
PHAR Transcript
The earnings call indicates significant challenges, particularly in Europe with EBITDA losses and high log costs. The Q&A highlights these issues, with management expecting improvements only by 2026. The company's financial health shows net debt and liquidity, but the uncertain path for Canfor Pulp and vague management responses on strategy further contribute to a negative outlook. While North American operations show some resilience, the overall sentiment leans negative due to European struggles and lack of clear strategic direction.
The earnings call reveals strong financial performance with a 32% revenue increase and improved margins, alongside optimistic guidance and a raised revenue forecast. Product developments, particularly Joenja's expansion, are promising. While some uncertainties exist, such as RUCONEST's withdrawal impact, the overall sentiment remains positive due to the strong growth trajectory and strategic direction.
The earnings call presents a largely positive outlook with strong revenue and profit growth, increased cash reserves, and raised revenue guidance. Despite some execution challenges in G&A expense reduction and potential bottlenecks in patient reclassification, the market strategy and financial health are solid. The Q&A section highlighted management's confidence in overcoming these challenges. The positive sentiment is reinforced by the company's strategic geographic expansion and robust product performance, notably RUCONEST and Joenja. These factors suggest a positive stock price movement in the short term.
The earnings report shows strong financial performance with a 42% revenue increase and improved gross margins. While there are risks related to regulatory issues and acquisition costs, the raised revenue guidance and ongoing growth in RUCONEST and Joenja are positive indicators. The reduction in G&A expenses suggests financial discipline. The Q&A reveals some uncertainties, but management's focus on growth and optimization is clear. Given these factors, the stock is likely to experience a positive movement in the short term.
PHAR Report
Frequently Asked Questions
What is the Pharming Group NV DEC/2025 Earnings Release Date and Time?
Pharming Group NV (PHAR) is scheduled to release its DEC/2025 earnings report on Mar 12, 2026, Pre-Market (approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Pharming Group NV DEC/2025 Revenue and EPS?
Analysts' consensus predicts 102.04M in revenue and an EPS of 0.15 for Pharming Group NV's DEC/2025.
What Does Intellectia's AI Predict for Pharming Group NV DEC/2025 Earnings?
Intellectia's exclusive AI algorithms forecast a {conclusion} for Pharming Group NV's DEC/2025 earnings, with a prediction date of Mar 12, 2026. Pharming Group NV {summary}
How Can I Use This Earnings Prediction to Trade PHAR Stock?
Leverage Intellectia's AI forecast to position trades ahead of the Mar 12, 2026 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Pharming Group NV DEC/2025?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company's earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They're updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
